Heliad Equity Partners (HPBK) - NAV decline driven by listed holdings

19:31 EDT 5 Oct 2018 | Edison Investment Research

Edison Investment Research - Investment Companies - Heliad Equity Partners: Heliad’s results and NAV were influenced by the overall conditions in the equity markets, with all but one listed holding (DEAG Deutsche Entertainment) posting a share price decline in H118. Major portfolio developments during the period include the reduction of the FinTech Group stake, participation in the pre-IPO funding round of Cyan and acquisition of Cubitabo by Sleepz. Heliad’s shares currently trade at a 29% discount to the last reported NAV of €10.38 (as at end-June 2018), with an even wider discount if we take into account FinTech’s current share price.

Original Article: Heliad Equity Partners (HPBK) - NAV decline driven by listed holdings


More From BioPortfolio on "Heliad Equity Partners (HPBK) - NAV decline driven by listed holdings"

Quick Search


Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...